AKT1 and lung cancer: Notably, JFAD-M administration yielded a stronger antitumor effect than either JFAD-L or JFAD-H, corroborating earlier reports that JFAD inhibits lung cancer invasion and metastasis in vivo through regulation of the PI3K/AKT pathway (Peng et al., 2024).